Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ITMCTR2026001046) titled 'A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Exploratory Clinical Trial on the Efficacy of Rapid-acting in the Treatment of Microvascular Angina' on April 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Tianjin University of Traditional Chinese Medicine

Condition: Microvascular angina

Intervention: Experimental Group:Basic treatment for microvascular angina + Suxiao Jiuxin Wan. Take 6 pills of Suxiao Jiuxin Wan each time, 3 times a day, sublingual administration.

Recruitment Status: Not Recruiting

Phase: Pilot clinical trial

Date of First Enrollment: 2026-04...